However, in this study, on an examination of cross-sections, primary CRC revealed heterogenous CDX2 expression, and 21.9% (30/137) of CDX2-positive primary CRCs also had CDX2-negative cancer cells in the tumor (Figure 2). This evidence concerns the gene CDX2 and cancer.